Literature DB >> 10225840

Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

H Tachibana1, X J Cheng, K Watanabe, M Takekoshi, F Maeda, S Aotsuka, Y Kaneda, T Takeuchi, S Ihara.   

Abstract

Genes coding for human antibody Fab fragments specific for Entamoeba histolytica were cloned and expressed in Escherichia coli. Lymphocytes were separated from the peripheral blood of a patient with an amebic liver abscess. Poly(A)+ RNA was isolated from the lymphocytes, and then genes coding for the light chain and Fd region of the heavy chain were amplified by a reverse transcriptase PCR. The amplified DNA fragments were ligated with a plasmid vector and were introduced into Escherichia coli. Three thousand colonies were screened for the production of antibodies to E. histolytica HM-1:IMSS by an indirect fluorescence-antibody (IFA) test. Lysates from five Escherichia coli clones were positive. Analysis of the DNA sequences of the five clones showed that three of the five heavy-chain sequences and four of the five light-chain sequences differed from each other. When the reactivities of the Escherichia coli lysates to nine reference strains of E. histolytica were examined by the IFA test, three Fab fragments with different DNA sequences were found to react with all nine strains and another Fab fragment was found to react with seven strains. None of the four human monoclonal antibody Fab fragments reacted with Entamoeba dispar reference strains or with other enteric protozoan parasites. These results indicate that the bacterial expression system reported here is effective for the production of human monoclonal antibodies specific for E. histolytica. The recombinant human monoclonal antibody Fab fragments may be applicable for distinguishing E. histolytica from E. dispar and for use in the serodiagnosis of amebiasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225840      PMCID: PMC103727          DOI: 10.1128/CDLI.6.3.383-387.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  36 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a beta2 integrin motif.

Authors:  R R Vines; G Ramakrishnan; J B Rogers; L A Lockhart; B J Mann; W A Petri
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

3.  Entamoeba dispar: cultivation without viable associate and its characterization.

Authors:  T Takeuchi; S Kobayashi
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

4.  Entamoeba taxonomy.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

5.  Differentiation of Entamoeba histolytica from E. dispar facilitated by monoclonal antibodies against a 150-kDa surface antigen.

Authors:  H Tachibana; S Kobayashi; X J Cheng; E Hiwatashi
Journal:  Parasitol Res       Date:  1997       Impact factor: 2.289

6.  Recombinant mouse-human chimeric antibodies as calibrators in immunoassays that measure antibodies to Toxoplasma gondii.

Authors:  J Hackett; J Hoff-Velk; A Golden; J Brashear; J Robinson; M Rapp; M Klass; D H Ostrow; W Mandecki
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 7.  Human antibodies from combinatorial libraries.

Authors:  D R Burton; C F Barbas
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

8.  Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies.

Authors:  K B Seydel; K L Braun; T Zhang; T F Jackson; S L Stanley
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

9.  Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces.

Authors:  M D Abd-Alla; T F Jackson; V Gathiram; A M el-Hawey; J I Ravdin
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

10.  Short report: detection of Entamoeba histolytica and E. dispar directly in stool.

Authors:  R Haque; L M Neville; S Wood; W A Petri
Journal:  Am J Trop Med Hyg       Date:  1994-05       Impact factor: 2.345

View more
  10 in total

1.  Modification of a human monoclonal antibody Fab fragment specific for Plasmodium falciparum 19-kDa C-terminal merozoite surface protein 1 by site-directed mutagenesis.

Authors:  Yan-Lin Tao; Xun-Jia Cheng; Yong-Feng Fu; Hideo Tsukamoto; Eisaku Yoshihara; Hiroshi Tachibana
Journal:  Parasitol Res       Date:  2008-04-30       Impact factor: 2.289

2.  Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS.

Authors:  Jinye Liu; Hongxia Shao; Yanlin Tao; Bin Yang; Lisheng Qian; Xiaoli Yang; Brian Cao; Gengxi Hu; Hiroshi Tachibana; Xunjia Cheng
Journal:  Clin Vaccine Immunol       Date:  2006-05

3.  Expression and characterization of an enantioselective antigen-binding fragment directed against α-amino acids.

Authors:  Pierre P Eleniste; Heike Hofstetter; Oliver Hofstetter
Journal:  Protein Expr Purif       Date:  2013-07-01       Impact factor: 1.650

4.  Improved affinity of a human anti-Entamoeba histolytica Gal/GalNAc lectin Fab fragment by a single amino acid modification of the light chain.

Authors:  Hiroshi Tachibana; Naohisa Matsumoto; Xun-Jia Cheng; Hideo Tsukamoto; Eisaku Yoshihara
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites.

Authors:  Yong-Feng Fu; Meng Feng; Kenji Ohnishi; Tamon Kimura; Johbu Itoh; Xun-Jia Cheng; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2010-10-18       Impact factor: 3.441

6.  Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.

Authors:  Xun-Jia Cheng; Hitoshi Hayasaka; Katsuomi Watanabe; Yan-Lin Tao; Jin-Ye Liu; Hideo Tsukamoto; Toshihiro Horii; Kazuyuki Tanabe; Hiroshi Tachibana
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

7.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR and enzyme-linked immunosorbent assay.

Authors:  Patrick Gonin; Louise Trudel
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Bacterial expression of a human monoclonal antibody-alkaline phosphatase conjugate specific for Entamoeba histolytica.

Authors:  Hiroshi Tachibana; Masataka Takekoshi; Xun-Jia Cheng; Yuta Nakata; Tsutomu Takeuchi; Seiji Ihara
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Characterization of Entamoeba histolytica intermediate subunit lectin-specific human monoclonal antibodies generated in transgenic mice expressing human immunoglobulin loci.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Hideo Tsukamoto; Johbu Itoh
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.